Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
One tablet every eight hours, beginning with "Tablet 1", or as directed by a physician. Store at controlled room temperature. NOTICE: Contact with moisture can discolor or erode tablets.
www.missionpharmacal.comA prescription prenatal supplement with 1 mg folic acid and a high level of vitamin B6 which may act as an antiemetic.
CitraNatal® B-Calm™ is a prescription prenatal multivitamin/mineral tablet with a high level of B6, along with two vitamin B6 tablets. The prenatal tablet is white, coated, modified oval, and is debossed with "0866" on one side and is blank on the other. The B6 25 mg tablets are white to off-white, uncoated, round, and are debossed with "B" on one side and "6" on the other.
Each prenatal tablet contains:
| Vitamin C (Ascorbic acid) | 120 mg |
| Calcium (Calcium citrate) | 125 mg |
| Iron (Carbonyl iron) | 20 mg |
| Vitamin D3 (Cholecalciferol) | 400 IU |
| Vitamin B6 (Pyridoxine HCl) | 25 mg |
| Folic Acid | 1 mg |
Each vitamin B6 tablet contains:
| Vitamin B6 (Pyridoxine HCl) | 25 mg |
CitraNatal® B-Calm™ is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. CitraNatal® B-Calm™ may be used in conjunction with a physician prescribed regimen to help minimize pregnancy related nausea and vomiting.
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Folic acid in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive.
Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
One tablet every eight hours, beginning with "Tablet 1", or as directed by a physician.
Store at controlled room temperature.
NOTICE: Contact with moisture can discolor or erode tablets.
Six child-resistant blister packs of 5 multivitamin/multimineral tablets and 10 vitamin B6 tablets each - NDC 0178-0866-30.
To report a serious adverse event or obtain product information, call (210) 696-8400.
50307 C01 REV 010090
MISSION PHARMACAL COMPANY
San Antonio, TX USA 78230 1355
www.missionpharmacal.com
Copyright © 2009 Mission Pharmacal Company.
All rights reserved.
*March of Dimes does not endorse specific products or brands. March of dimes is a registered trademark of the March of Dimes Foundation.
Rx Only
NDC 0178-0866-30
The gentle option for
additional B6
CitraNatal®
B-Calm
Rx Prenatal Vitamin with two 25 mg each Vitamin B6 tablets
A prescription
prenatal supplement
with 1 mg of folic
acid and a high level
of vitamin B6 which
may act as an
antiemetic.
march of dimes®
Mission Pharmacal is a proud
supporter of the March of Dimes.®
CONTAINS
Six 5-day Blister Packs
Mission®
PHARMACAL
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1100471 | {30 (ascorbic acid 120 MG / calcium citrate 125 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 20 MG / pyridoxine hydrochloride 25 MG Oral Tablet) / 10 (pyridoxine hydrochloride 25 MG Oral Tablet) } Pack [CitraNatal B-Calm Kit] | BPCK | 1 |
| 1100470 | {30 (ascorbic acid 120 MG / calcium citrate 125 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 20 MG / pyridoxine hydrochloride 25 MG Oral Tablet) / 10 (pyridoxine hydrochloride 25 MG Oral Tablet) } Pack | GPCK | 1 |
| 1100471 | CitraNatal B-Calm 30 Day Pack | PSN | 1 |
| 1100457 | pyridoxine HCl 25 MG Oral Tablet | PSN | 1 |
| 1100262 | ascorbic acid 120 MG / calcium citrate 125 MG / cholecalciferol 400 UNT / folic acid 1 MG / iron carbonyl 20 MG / pyridoxine hydrochloride 25 MG Oral Tablet | SCD | 1 |
| 1100457 | pyridoxine hydrochloride 25 MG Oral Tablet | SCD | 1 |
| 1100262 | calcium citrate 125 MG / folic acid 1 MG / iron carbonyl 20 MG / vitamin B6 25 MG / vitamin C 120 MG / vitamin D3 400 UNT Oral Tablet | SY | 1 |
| 1100471 | CitraNatal B-Calm 30 Day Pack | SY | 1 |
| 1100457 | vit-B6 Hydrochloride 25 MG Oral Tablet | SY | 1 |
| 1100262 | vit-C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / folate 1 MG / Iron Carbonyl 20 MG / vit-B6 Hydrochloride 25 MG Oral Tablet | SY | 1 |
| 1100262 | vit-C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / folate 1 MG / Iron Carbonyl 20 MG / vitamin B6 Hydrochloride 25 MG Oral Tablet | SY | 1 |
| 1100457 | vitamin B6 Hydrochloride 25 MG Oral Tablet | SY | 1 |
| 1100262 | vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / folate 1 MG / Iron Carbonyl 20 MG / vit-B6 Hydrochloride 25 MG Oral Tablet | SY | 1 |
| 1100262 | vitamin C 120 MG / Calcium Citrate 125 MG / Cholecalciferol 400 UNT / folate 1 MG / Iron Carbonyl 20 MG / vitamin B6 Hydrochloride 25 MG Oral Tablet | SY | 1 |
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| 91c62db0-0295-c81c-d10a-0856c259edd6 | Product name | 2 | 20200428 |
| d32bc2b8-0bb7-2216-87aa-24639646e202 | Product name | 3 | 20190619 |
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
| 60c52429-fcef-eb54-2387-43bc9e4f296b | Product name | 1 | 20140508 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0178-0866-30 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c929-8e05-e053-dbdaa90a074a | CitraNatal ® B-Calm Rx Prenatal Vitamin with two 25 mg each Vitamin B 6 tablets |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0178-0866-30 | CitraNatalB-Calm | 1 in 1 BLISTER PACK | KIT | 1 | 1 | |
| 0178-0866-30 | CitraNatalB-Calm | 5 in 1 CARTON | KIT | 5 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0178-0866 | CITRANATAL B-CALM (ASCORBIC ACID, CALCIUM CITRATE, IRON PENTACARBONYL, CHOLECALCIFEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID) KIT [MISSION PHARMACAL COMPANY] | 1 | Legacy NDC, 2 package rows | 20110428_b7846220-4137-4f1f-aea8-cd47e992a845.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ascorbic acid | ACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| calcium citrate | ACTIVE INGREDIENT | MLM29U2X85 | 1 | |
| Cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 1 | |
| folic acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| Iron Pentacarbonyl | ACTIVE INGREDIENT | 6WQ62TAQ6Z | 1 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| ascorbic acid | ACTIVE MOIETY | PQ6CK8PD0R | 1 | |
| calcium | ACTIVE MOIETY | SY7Q814VUP | 1 | |
| Cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 1 | |
| folic acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| Iron Pentacarbonyl | ACTIVE MOIETY | 6WQ62TAQ6Z | 1 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| Hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| Magnesium Silicate | INACTIVE INGREDIENT | 9B9691B2N9 | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| Polyethylene Glycol | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 | |
| Povidone | INACTIVE INGREDIENT | FZ989GH94E | 1 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Vitamin A Palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0178-0866 | 0178-0866-30 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Magnesium Silicate | MAGNESIUM SILICATE | 9B9691B2N9 | WAFER / ORAL | 22 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, COATED / ORAL | 17 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, EXTENDED RELEASE / ORAL | 90 mg | ||
| Povidone | POVIDONE | FZ989GH94E | TROCHE / ORAL | 30 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| Povidone | POVIDONE | FZ989GH94E | CAPSULE, DELAYED RELEASE / ORAL | NA | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / OPHTHALMIC | 0.5 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE / ORAL | 29520 mg | ||
| Magnesium Silicate | MAGNESIUM SILICATE | 9B9691B2N9 | SOAP / TOPICAL | 0.33 %w/w | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GRANULE, FOR SUSPENSION / ORAL | 1.7 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 11 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, ORALLY DISINTEGRATING / ORAL | 6 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| Povidone | POVIDONE | FZ989GH94E | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, EXTENDED RELEASE / ORAL | 1472 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, DELAYED RELEASE / ORAL | 366 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| Povidone | POVIDONE | FZ989GH94E | TABLET / SUBLINGUAL | 6 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, COATED PELLETS / ORAL | 456 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| Povidone | POVIDONE | FZ989GH94E | INJECTION / INTRAMUSCULAR | 0.2 %w/v | ||
| Povidone | POVIDONE | FZ989GH94E | SOLUTION / ORAL | 3000 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Magnesium Silicate | MAGNESIUM SILICATE | 9B9691B2N9 | TABLET, FILM COATED / ORAL | 33.7 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| Povidone | POVIDONE | FZ989GH94E | SUSPENSION / ORAL | 20 mg/5ml | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / RESPIRATORY (INHALATION) | 2 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | SUSPENSION / ORAL | 1600 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER / ORAL | 2 mg | ||
| Povidone | POVIDONE | FZ989GH94E | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 32 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | 250 mg | ||
| Povidone | POVIDONE | FZ989GH94E | SOLUTION / OPHTHALMIC | 1.8 %w/v | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING / ORAL | 1800 mg | ||
| Magnesium Silicate | MAGNESIUM SILICATE | 9B9691B2N9 | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| Povidone | POVIDONE | FZ989GH94E | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 350 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, DELAYED RELEASE / ORAL | 79 mg | ||
| Povidone | POVIDONE | FZ989GH94E | TABLET, COATED / ORAL | 49.2 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| Magnesium Silicate | MAGNESIUM SILICATE | 9B9691B2N9 | TABLET / ORAL | 10 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| Magnesium Silicate | MAGNESIUM SILICATE | 9B9691B2N9 | TABLET / SUBLINGUAL | 1.2 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 03d6e2ba-0ef8-48ad-ab6f-959bfbabbbf7 | b7846220-4137-4f1f-aea8-cd47e992a845 | 2010-05-03 | Boxed warning, Warnings, Adverse reactions | 03d6e2ba-0ef8-48ad-ab6f-959bfbabbbf7 b7846220-4137-4f1f-aea8-cd47e992a845 |
Adverse event summaries are temporarily unavailable. Other product information remains available.